Journal Articles
International Journal of Radiation Oncology, Biology, Physics
Year : 2010
Stéphane Delmotte : Connect in order to contact the contributor
https://hal.science/hal-00698359
Submitted on : Wednesday, May 16, 2012-2:34:27 PM
Last modification on : Friday, March 24, 2023-2:52:55 PM
Dates and versions
Identifiers
- HAL Id : hal-00698359 , version 1
Cite
Nicolas Girard, F. Mornex, Nadine Bossard, M. Ychou, B. Chauffert, et al.. Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 phase I trial. International Journal of Radiation Oncology, Biology, Physics, 2010, 77(5), pp.1426-1432. ⟨hal-00698359⟩
76
View
0
Download